The North America Body Fluid Collection And Diagnostics Market would witness market growth of 6.5% CAGR during the forecast period (2022-2028).
The body fluid of humans contains saliva, blood, excreta, cerebrospinal fluid, and fluids of tissues are considered inviting sources for clinical biomarkers, specifically in chronic diseases which extremely impact human life. The examination of human body fluid allows for diagnosing diseases and tracking disease causes. It enables the forecast of prognosis and tracking of disease growth with affordability, less invasiveness, and quick sample collection & analysis.
Moreover, the structure of molecular expression level in the body fluid can assist in the revelation of modification of psychological position and cellular in the affected tissue. Thus, body fluid analysis is the most valuable process for the identification, tracking, management, and pre-response analysis of chronic disease and for reveling the possible pathogens of chronic disease.
By the body fluid analysis process, which is considered as a most favorable approaches in practice, one can identify chronic diseases like diabetes, hypertension, cancer, and glaucoma. This can help on building a more inclusive approach to the mechanism of pathology and physiology in chronic diseases, which could have a crucial role in offering early proof, more productive care, and greater patient results.
As per the Canadian Cancer Statistic by Canadian government, throughout the life period of a Canadian citizen, 43% of Canadian women and 45% of Canadian men have cancer. As the population of Canada will rise and become older, there will be increasing cases of new cancer patients. Cancer is the major cause of many deaths in Canada. Apart from the present improvement in cancer management and research, rising partiality care of cancer patients has been seen, especially with those who are socio-economically disadvantaged groups and under-served society.
The government of Canada is supporting those organizations who are helping out to fight against this disease. The Canadian government recently introduced a plan to offer $250 million dollars for five years to expand the work of these organizations that are fighting against cancer. With the rising number of cancer patients in Canada, there will be great investment opportunities for the major players in the regional market.
The US market dominated the North America Body Fluid Collection And Diagnostics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $12,613.9 million by 2028. The Canada market is poised to grow at a CAGR of 8.9% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 7.9% during (2022 - 2028).
Based on Product, the market is segmented into Kits & Consumables, Instruments and Tests/Services. Based on Technology, the market is segmented into Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Fluorescence in situ hybridization (FISH) and Others. Based on Sample Type, the market is segmented into Blood, Urine, Saliva and Cerebrospinal Fluid. Based on Application, the market is segmented into Diagnostics & Monitoring, Therapeutic Decision Making and Prognostics & Screening. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Body Fluid Collection And Diagnostics Market is Estimated to reach $42.2 Billion by 2028, at a CAGR of 6.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., Qiagen N.V., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Biocept, Inc., MDxHealth SA, and Guardant Health, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Kits & Consumables
- Instruments
- Tests/Services
By Technology
- Polymerase Chain Reaction (PCR)
- Next Generation Sequencing (NGS)
- Fluorescence in situ hybridization (FISH)
- Others
By Sample Type
- Blood
- Urine
- Saliva
- Cerebrospinal Fluid
By Application
- Diagnostics & Monitoring
- Therapeutic Decision Making
- Prognostics & Screening
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Illumina, Inc.
- Qiagen N.V.
- Johnson & Johnson
- F.Hoffmann-La Roche Ltd.
- Laboratory Corporation of America Holdings
- Biocept, Inc.
- MDxHealth SA
- Guardant Health, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Body Fluid Collection And Diagnostics Market, by Product
1.4.2 North America Body Fluid Collection And Diagnostics Market, by Technology
1.4.3 North America Body Fluid Collection And Diagnostics Market, by Sample Type
1.4.4 North America Body Fluid Collection And Diagnostics Market, by Application
1.4.5 North America Body Fluid Collection And Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2021, Jan – 2022, Sep) Leading Players
Chapter 4. North America Body Fluid Collection And Diagnostics Market by Product
4.1 North America Kits & Consumables Market by Country
4.2 North America Instruments Market by Country
4.3 North America Tests/Services Market by Country
Chapter 5. North America Body Fluid Collection And Diagnostics Market by Technology
5.1 North America Polymerase Chain Reaction (PCR) Market by Country
5.2 North America Next Generation Sequencing (NGS) Market by Country
5.3 North America Fluorescence in situ hybridization (FISH) Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Body Fluid Collection And Diagnostics Market by Sample Type
6.1 North America Blood Market by Country
6.2 North America Urine Market by Country
6.3 North America Saliva Market by Country
6.4 North America Cerebrospinal Fluid Market by Country
Chapter 7. North America Body Fluid Collection And Diagnostics Market by Application
7.1 North America Diagnostics & Monitoring Market by Country
7.2 North America Therapeutic Decision Making Market by Country
7.3 North America Prognostics & Screening Market by Country
Chapter 8. North America Body Fluid Collection And Diagnostics Market by Country
8.1 US Body Fluid Collection And Diagnostics Market
8.1.1 US Body Fluid Collection And Diagnostics Market by Product
8.1.2 US Body Fluid Collection And Diagnostics Market by Technology
8.1.3 US Body Fluid Collection And Diagnostics Market by Sample Type
8.1.4 US Body Fluid Collection And Diagnostics Market by Application
8.2 Canada Body Fluid Collection And Diagnostics Market
8.2.1 Canada Body Fluid Collection And Diagnostics Market by Product
8.2.2 Canada Body Fluid Collection And Diagnostics Market by Technology
8.2.3 Canada Body Fluid Collection And Diagnostics Market by Sample Type
8.2.4 Canada Body Fluid Collection And Diagnostics Market by Application
8.3 Mexico Body Fluid Collection And Diagnostics Market
8.3.1 Mexico Body Fluid Collection And Diagnostics Market by Product
8.3.2 Mexico Body Fluid Collection And Diagnostics Market by Technology
8.3.3 Mexico Body Fluid Collection And Diagnostics Market by Sample Type
8.3.4 Mexico Body Fluid Collection And Diagnostics Market by Application
8.4 Rest of North America Body Fluid Collection And Diagnostics Market
8.4.1 Rest of North America Body Fluid Collection And Diagnostics Market by Product
8.4.2 Rest of North America Body Fluid Collection And Diagnostics Market by Technology
8.4.3 Rest of North America Body Fluid Collection And Diagnostics Market by Sample Type
8.4.4 Rest of North America Body Fluid Collection And Diagnostics Market by Application
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.2 Guardant Health, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.5.3 Acquisition and Mergers:
9.3 Illumina, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Acquisition and Mergers:
9.4 Qiagen N.V.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Acquisition and Mergers:
9.5 Bio-Rad Laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.6 F. Hoffmann-La Roche Ltd.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Product Launches and Product Expansions:
9.7 Laboratory Corporation of America Holdings
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental Analysis
9.7.4 Recent strategies and developments:
9.7.4.1 Partnerships, Collaborations, and Agreements:
9.8 Johnson & Johnson
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental &Regional Analysis
9.8.4 Research & Development Expenses
9.9 Biocept, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Research & Development Expenses
9.9.4 Recent strategies and developments:
9.9.4.1 Partnerships, Collaborations, and Agreements:
9.9.4.2 Product Launches and Product Expansions:
9.10. MDxHealth SA
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Regional Analysis
9.10.4 Research & Development Expenses
TABLE 1 North America Body Fluid Collection And Diagnostics Market, 2018 - 2021, USD Million
TABLE 2 North America Body Fluid Collection And Diagnostics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Body Fluid Collection And Diagnostics Market
TABLE 4 Product Launches And Product Expansions– Body Fluid Collection And Diagnostics Market
TABLE 5 Acquisition and Mergers– Body Fluid Collection And Diagnostics Market
TABLE 6 North America Body Fluid Collection And Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 7 North America Body Fluid Collection And Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 8 North America Kits & Consumables Market by Country, 2018 - 2021, USD Million
TABLE 9 North America Kits & Consumables Market by Country, 2022 - 2028, USD Million
TABLE 10 North America Instruments Market by Country, 2018 - 2021, USD Million
TABLE 11 North America Instruments Market by Country, 2022 - 2028, USD Million
TABLE 12 North America Tests/Services Market by Country, 2018 - 2021, USD Million
TABLE 13 North America Tests/Services Market by Country, 2022 - 2028, USD Million
TABLE 14 North America Body Fluid Collection And Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 15 North America Body Fluid Collection And Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 16 North America Polymerase Chain Reaction (PCR) Market by Country, 2018 - 2021, USD Million
TABLE 17 North America Polymerase Chain Reaction (PCR) Market by Country, 2022 - 2028, USD Million
TABLE 18 North America Next Generation Sequencing (NGS) Market by Country, 2018 - 2021, USD Million
TABLE 19 North America Next Generation Sequencing (NGS) Market by Country, 2022 - 2028, USD Million
TABLE 20 North America Fluorescence in situ hybridization (FISH) Market by Country, 2018 - 2021, USD Million
TABLE 21 North America Fluorescence in situ hybridization (FISH) Market by Country, 2022 - 2028, USD Million
TABLE 22 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 23 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 24 North America Body Fluid Collection And Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 25 North America Body Fluid Collection And Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 26 North America Blood Market by Country, 2018 - 2021, USD Million
TABLE 27 North America Blood Market by Country, 2022 - 2028, USD Million
TABLE 28 North America Urine Market by Country, 2018 - 2021, USD Million
TABLE 29 North America Urine Market by Country, 2022 - 2028, USD Million
TABLE 30 North America Saliva Market by Country, 2018 - 2021, USD Million
TABLE 31 North America Saliva Market by Country, 2022 - 2028, USD Million
TABLE 32 North America Cerebrospinal Fluid Market by Country, 2018 - 2021, USD Million
TABLE 33 North America Cerebrospinal Fluid Market by Country, 2022 - 2028, USD Million
TABLE 34 North America Body Fluid Collection And Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 35 North America Body Fluid Collection And Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 36 North America Diagnostics & Monitoring Market by Country, 2018 - 2021, USD Million
TABLE 37 North America Diagnostics & Monitoring Market by Country, 2022 - 2028, USD Million
TABLE 38 North America Therapeutic Decision Making Market by Country, 2018 - 2021, USD Million
TABLE 39 North America Therapeutic Decision Making Market by Country, 2022 - 2028, USD Million
TABLE 40 North America Prognostics & Screening Market by Country, 2018 - 2021, USD Million
TABLE 41 North America Prognostics & Screening Market by Country, 2022 - 2028, USD Million
TABLE 42 North America Body Fluid Collection And Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 43 North America Body Fluid Collection And Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 44 US Body Fluid Collection And Diagnostics Market, 2018 - 2021, USD Million
TABLE 45 US Body Fluid Collection And Diagnostics Market, 2022 - 2028, USD Million
TABLE 46 US Body Fluid Collection And Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 47 US Body Fluid Collection And Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 48 US Body Fluid Collection And Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 49 US Body Fluid Collection And Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 50 US Body Fluid Collection And Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 51 US Body Fluid Collection And Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 52 US Body Fluid Collection And Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 53 US Body Fluid Collection And Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 54 Canada Body Fluid Collection And Diagnostics Market, 2018 - 2021, USD Million
TABLE 55 Canada Body Fluid Collection And Diagnostics Market, 2022 - 2028, USD Million
TABLE 56 Canada Body Fluid Collection And Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 57 Canada Body Fluid Collection And Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 58 Canada Body Fluid Collection And Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 59 Canada Body Fluid Collection And Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 60 Canada Body Fluid Collection And Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 61 Canada Body Fluid Collection And Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 62 Canada Body Fluid Collection And Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 63 Canada Body Fluid Collection And Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 64 Mexico Body Fluid Collection And Diagnostics Market, 2018 - 2021, USD Million
TABLE 65 Mexico Body Fluid Collection And Diagnostics Market, 2022 - 2028, USD Million
TABLE 66 Mexico Body Fluid Collection And Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 67 Mexico Body Fluid Collection And Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 68 Mexico Body Fluid Collection And Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 69 Mexico Body Fluid Collection And Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 70 Mexico Body Fluid Collection And Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 71 Mexico Body Fluid Collection And Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 72 Mexico Body Fluid Collection And Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 73 Mexico Body Fluid Collection And Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 74 Rest of North America Body Fluid Collection And Diagnostics Market, 2018 - 2021, USD Million
TABLE 75 Rest of North America Body Fluid Collection And Diagnostics Market, 2022 - 2028, USD Million
TABLE 76 Rest of North America Body Fluid Collection And Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 77 Rest of North America Body Fluid Collection And Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 78 Rest of North America Body Fluid Collection And Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 79 Rest of North America Body Fluid Collection And Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 80 Rest of North America Body Fluid Collection And Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 81 Rest of North America Body Fluid Collection And Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 82 Rest of North America Body Fluid Collection And Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 83 Rest of North America Body Fluid Collection And Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 84 Key Information – Thermo Fisher Scientific, Inc.
TABLE 85 Key Information – GUARDANT HEALTH, INC.
TABLE 86 key information – Illumina, Inc.
TABLE 87 Key Information – Qiagen N.V.
TABLE 88 Key Information – Bio-Rad Laboratories, Inc.
TABLE 89 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 90 Key Information – Laboratory Corporation of America holdings
TABLE 91 Key information –Johnson & Johnson
TABLE 92 Key Information –Biocept, Inc.
TABLE 93 Key Information – MDXHEALTH SA
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements : 2021, Jan – 2022, Sep) Leading Players
FIG 5 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 6 Recent strategies and developments: Guardant Health, Inc.
FIG 7 Recent strategies and developments: Illumina, Inc.
FIG 8 Recent strategies and developments: Qiagen N.V.